Literature DB >> 22108787

Meta-structure correlation in protein space unveils different selection rules for folded and intrinsically disordered proteins.

Yandi Naranjo1, Miquel Pons, Robert Konrat.   

Abstract

The number of existing protein sequences spans a very small fraction of sequence space. Natural proteins have overcome a strong negative selective pressure to avoid the formation of insoluble aggregates. Stably folded globular proteins and intrinsically disordered proteins (IDPs) use alternative solutions to the aggregation problem. While in globular proteins folding minimizes the access to aggregation prone regions, IDPs on average display large exposed contact areas. Here, we introduce the concept of average meta-structure correlation maps to analyze sequence space. Using this novel conceptual view we show that representative ensembles of folded and ID proteins show distinct characteristics and respond differently to sequence randomization. By studying the way evolutionary constraints act on IDPs to disable a negative function (aggregation) we might gain insight into the mechanisms by which function-enabling information is encoded in IDPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108787     DOI: 10.1039/c1mb05367a

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  8 in total

1.  Protonation-dependent conformational variability of intrinsically disordered proteins.

Authors:  Leonhard Geist; Morkos A Henen; Sandra Haiderer; Thomas C Schwarz; Dennis Kurzbach; Anna Zawadzka-Kazimierczuk; Saurabh Saxena; Szymon Zerko; Wiktor Koźmiński; Dariush Hinderberger; Robert Konrat
Journal:  Protein Sci       Date:  2013-09       Impact factor: 6.725

Review 2.  Advantages of proteins being disordered.

Authors:  Zhirong Liu; Yongqi Huang
Journal:  Protein Sci       Date:  2014-03-17       Impact factor: 6.725

Review 3.  Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein.

Authors:  Jonathan K Williams; Xue Yang; Jean Baum
Journal:  Proteomics       Date:  2018-09-09       Impact factor: 3.984

4.  Random protein sequences can form defined secondary structures and are well-tolerated in vivo.

Authors:  Vyacheslav Tretyachenko; Jiří Vymětal; Lucie Bednárová; Vladimír Kopecký; Kateřina Hofbauerová; Helena Jindrová; Martin Hubálek; Radko Souček; Jan Konvalinka; Jiří Vondrášek; Klára Hlouchová
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

Review 5.  Structural Perspective on Revealing and Altering Molecular Functions of Genetic Variants Linked with Diseases.

Authors:  Yunhui Peng; Emil Alexov; Sankar Basu
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

6.  Sequence Versus Composition: What Prescribes IDP Biophysical Properties?

Authors:  Jiří Vymětal; Jiří Vondrášek; Klára Hlouchová
Journal:  Entropy (Basel)       Date:  2019-07-03       Impact factor: 2.524

7.  Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures.

Authors:  Marquiza Sablón-Carrazana; Isaac Fernández; Alberto Bencomo; Reyna Lara-Martínez; Suchitil Rivera-Marrero; Guadalupe Domínguez; Rafaela Pérez-Perera; Luis Felipe Jiménez-García; Nelly F Altamirano-Bustamante; Massiel Diaz-Delgado; Fernand Vedrenne; Lina Rivillas-Acevedo; Karina Pasten-Hidalgo; María de Lourdes Segura-Valdez; Sergio Islas-Andrade; Eulalia Garrido-Magaña; Alejandro Perera-Pintado; Anaís Prats-Capote; Chryslaine Rodríguez-Tanty; Myriam M Altamirano-Bustamante
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

8.  Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter.

Authors:  Cristina Fenollar-Ferrer; Thomas Stockner; Thomas C Schwarz; Aritra Pal; Jelena Gotovina; Tina Hofmaier; Kumaresan Jayaraman; Suraj Adhikary; Oliver Kudlacek; Ahmad Reza Mehdipour; Sotiria Tavoulari; Gary Rudnick; Satinder K Singh; Robert Konrat; Harald H Sitte; Lucy R Forrest
Journal:  Biochemistry       Date:  2014-08-15       Impact factor: 3.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.